BrightPath Biotherapeutics Co., Ltd. Stock
Equities
4594
JP3274140007
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58 JPY | +1.75% | -1.69% | -33.33% |
Sales 2017 | 529M 3.38M 4.61M | Sales 2018 | 354M 2.26M 3.09M | Capitalization | 33.68B 215M 294M |
---|---|---|---|---|---|
Net income 2017 | -1.11B -7.12M -9.71M | Net income 2018 | -1.58B -10.08M -13.75M | EV / Sales 2017 | 34.8 x |
Net cash position 2017 | 4.95B 31.65M 43.17M | Net cash position 2018 | 6.53B 41.74M 56.93M | EV / Sales 2018 | 76.7 x |
P/E ratio 2017 |
-19.2
x | P/E ratio 2018 |
-19.5
x | Employees | 42 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 95.53% |
1 day | +1.75% | ||
1 week | -1.69% | ||
Current month | -3.33% | ||
1 month | -3.33% | ||
3 months | -18.31% | ||
6 months | -49.12% | ||
Current year | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Kenichi Nagai
CEO | Chief Executive Officer | 54 | 08-12-31 |
Director/Board Member | 55 | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 15-05-31 | |
Akira Yamada
BRD | Director/Board Member | 67 | 03-04-30 |
Kenichi Nagai
CEO | Chief Executive Officer | 54 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 58 | +1.75% | 325 100 |
24-05-13 | 57 | 0.00% | 248,600 |
24-05-10 | 57 | -1.72% | 447,500 |
24-05-09 | 58 | -1.69% | 285,600 |
24-05-08 | 59 | 0.00% | 205,500 |
Delayed Quote Japan Exchange, May 14, 2024 at 02:00 am
More quotes1st Jan change | Capi. | |
---|---|---|
-33.33% | 25.81M | |
+29.58% | 48.16B | |
-0.74% | 41.73B | |
+45.09% | 41.03B | |
-5.31% | 28.77B | |
+10.81% | 25.59B | |
-22.39% | 18.96B | |
+8.59% | 12.92B | |
+28.78% | 12.03B | |
-2.42% | 11.77B |
- Stock Market
- Equities
- 4594 Stock